AMERICAN CENTURY COMPANIES INC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 748054 KANSAS CITY, MO

Position in CRNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$38,239,802

-$11,516,468 QoQ

Shares Held

1,052,858

-1.5% QoQ

Ownership

0.999%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 76.76182353175832.ToString("F0")% Shared 23.23817646824168.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AMERICAN CENTURY COMPANIES INC holds $3,844,311,104 across 169 Biotechnology names. CRNX ranks #25 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,802,363	$596,347,845
2	REGN	Regeneron Pharmaceuticals, Inc.	562,097	$434,298,626
3	VRTX	Vertex Pharmaceuticals Inc / Ma	813,285	$363,164,283
4	ASND	Ascendis Pharma A/S	1,397,119	$319,563,028
5	INSM	INSMED Inc	925,799	$151,386,652
6	ARGX	Argenx SE	173,700	$126,844,425
7	IONS	Ionis Pharmaceuticals Inc	1,663,803	$124,934,967
8	CPRX	Catalyst Pharmaceuticals, Inc.	4,138,416	$102,467,180

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$38,239,802	1,052,858	-1.5%	Shares	Defined	2026-05-15
2025-12-31	$49,756,270	1,068,878	-5.7%	Shares	Defined	2026-02-13
2025-09-30	$47,211,732	1,133,535	+33.6%	Shares	Defined	2025-11-12
2025-06-30	$24,406,828	848,638	+17.9%	Shares	Defined	2025-08-12
2025-03-31	$24,134,646	719,578	+50.8%	Shares	Defined	2025-05-13
2024-12-31	$24,404,246	477,298	+23.4%	Shares	Defined	2025-02-11
2024-09-30	$19,769,874	386,886	+3361.1%	Shares	Defined	2024-11-12
2024-06-30	$500,662	11,178	-11.0%	Shares	Defined	2024-08-07
2024-03-31	$587,839	12,558	-79.6%	Shares	Defined	2024-05-14
2023-12-31	$2,192,012	61,608	+219.5%	Shares	Defined	2024-02-13
2023-06-30	$347,479	19,283	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.